MedTrace Logo

Periodontal and Cardiometabolic Responses to Vitamin D Intervention in African Americans With Periodontal Disease

NCT02337257 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-01-13

No results posted yet for this study

Summary

Poor vitamin D status is very common in African Americans. Periodontitis (gum disease) are shown to be related to theincreased risk of cardiometabolic diseases. Vitamin D is freely available and cheap supplement that has shown beneficialeffect in the immune system regulation and maintenance of the cardiovascular health. In this study The investigators hypothesize thatvitamin D supplementation for 16 weeks in African Americans with periodontitis will result in clinical improvement in theirgum health as well as their cardiometabolic risk profile

Conditions

  • Periodontal Disease
  • Vitamin D Deficiency

Interventions

DRUG

Cholecalciferol

subjects will receive one pill per day which contains 4000 IU/d for 16 weeks

DRUG

Placebo

subjects will receive placebo one pill per day for 16 weeks

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Principal Investigators

  • Yanbin Dong, PhD · Augusta University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-09-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02337257 on ClinicalTrials.gov